Biomarkers in Medicine

Biomarkers in Medicine is published by Future Medicine Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Inflammatory Biomarkers in Disease Prognosis, MicroRNA in disease regulation and Cancer-related molecular mechanisms research, together about 23.9% of its articles. Its main subfields are Cancer Research. (generated from OpenAlex topic counts and CAS ranking data)

Biomarkers are physical, functional or biochemical indicators of physiological or disease processes. These key indicators can provide vital information in determining disease prognosis, in predicting of response to therapies, adverse events and drug interactions, and in establishing baseline risk. The explosion of interest in biomarker research is driving the development of new predictive, diagnostic and prognostic products in modern medical practice, and biomarkers are also playing an increasingly important role in the discovery and development of new drugs. For the full utility of biomarkers to be realized, we require greater understanding of disease mechanisms, and the interplay between disease mechanisms, therapeutic interventions and the proposed biomarkers. However, in attempting to evaluate the pros and cons of biomarkers systematically, we are moving into new, challenging territory. Biomarkers in Medicine (ISSN 1752-0363) is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice. As the scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development become more fully established, Biomarkers in Medicine provides the platform for all players in this increasingly vital area to communicate and debate all issues relating to the potential utility and applications. Each issue includes a diversity of content to provide rounded coverage for the research professional. Articles include Guest Editorials, Interviews, Reviews, Research Articles, Perspectives, Priority Paper Evaluations, Special Reports, Case Reports, Conference Reports and Company Profiles. Review coverage is divided into themed sections according to area of therapeutic utility with some issues including themed sections on an area of topical interest. Biomarkers in Medicine provides a platform for commentary and debate for all professionals with an interest in the identification of biomarkers, elucidation of their role and formalization and approval of their application in modern medicine. The audience for Biomarkers in Medicine includes academic and industrial researchers, clinicians, pathologists, clinical chemists and regulatory professionals.

Source: LetPub

Research area (LetPub): Medicine, Research & Experimental

CAS Journal Ranking

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

2.37LetPub · 2026-09-13

CiteScore 2026-06

3.2LetPub · 2026-09-13

SJR 2026-06

0.58LetPub · 2026-09-13

SNIP 2026-06

0.62LetPub · 2026-09-13

h-index

37LetPub · 2026-09-13

h-index

73OpenAlex · 2026-10-01

i10-index

993OpenAlex · 2026-10-01

2-year mean citedness

2.16OpenAlex · 2026-10-01

Self-citation rate

4.8%LetPub · 2026-09-13

Share of gold OA articles

4.08%LetPub · 2026-09-13

Volume

Articles per year

130LetPub · 2026-09-13

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Other sources

Average review time (community reports)

6–12 weeksLetPub · 2026-09-13

Average acceptance (community reports)

ModerateLetPub · 2026-09-13

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

No source has fee information yet; check the journal's website.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Publisher

Future Medicine Ltd.

Country or region

ENGLAND

Language

English

Frequency

Bimonthly

Founded

2007

ISSN

1752-0363

Electronic ISSN

1752-0371

Official links

• Journal homepage ↗LetPub
• Submission system ↗LetPub